Business
– RedHill Biopharma Ltd. (Redhill) reported positive pharmacokinetic (PK) clinical studies for their planned new drug application (NDA) for their RHB-102 extended release Anti-Emetic product. RedHill is an emerging Israeli...
Hi, what are you looking for?
– RedHill Biopharma Ltd. (Redhill) reported positive pharmacokinetic (PK) clinical studies for their planned new drug application (NDA) for their RHB-102 extended release Anti-Emetic product. RedHill is an emerging Israeli...
– – Neuronix, founded in Israel in 2008, has developed an innovative medical device technology for the treatment of Alzheimer’s Disease (AD). The technology...
– /By Ilan Shavit / Teva Women’s Health, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that the U.S. Food and...
– Researchers at Tel Aviv University have discovered that selling nutritional supplement may be effective against degenerative diseases of the brain and nervous system....